98 results
S-8
NUVB
Nuvation Bio Inc - Ordinary Shares
18 Apr 24
Registration of securities for employees
4:56pm
of which would be uncertain and could negatively impact the success of our business.
Intellectual property litigation could cause us to spend substantial
8-K
EX-2.1
NUVB
Nuvation Bio Inc - Ordinary Shares
25 Mar 24
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
7:06am
Accuracy of Representations and Warranties
7.2
Performance of Covenants
7.3
Dissenting Shareholders
7.4
No Governmental Litigation
7.5
Agreements …
Accuracy of Representations and Warranties
8.2
Performance of Covenants
8.3
No Governmental Litigation
8.4
Closing Certificate
8.5
No Parent Material
8-K
NUVB
Nuvation Bio Inc - Ordinary Shares
25 Mar 24
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
7:06am
statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements
8-K
EX-99.1
s4vls
25 Mar 24
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
7:06am
8-K
EX-99.2
f6w1xe p1s11l3i5swx
25 Mar 24
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
7:06am
8-K
EX-99.1
g2s2bce25ex6h16x
29 Feb 24
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:48pm
8-K
EX-99.1
nwmnd94m
2 Nov 23
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
4:23pm
8-K
EX-99.1
z2j hv4iae2e3sfyz11t
3 Aug 23
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
4:17pm
8-K
EX-99.1
9em 3r1ysdsnz
4 May 23
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update
12:00am
8-K
EX-99.1
dgepbkgb 66r
23 Dec 22
Regulation FD Disclosure
4:26pm
8-K
EX-99.1
jq9b5pmd
3 Nov 22
Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides
4:13pm